Pluripotential Mechanisms of Cardioprotection with HMG-CoA Reductase Inhibitor Therapy

By Rosenson R.S.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 411-420

Adis International

Access to resources Recommend Favorite

Synthesis and Biological Evaluation of Atorvastatin Derivatives as Novel HMG-CoA Reductase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 9, 2013-01 ,pp. : 817-822

Bentham Science Publishers

Access to resources Recommend Favorite

Cerivastatin: the low-dose HMG-COA reductase inhibitor

By Tikkanen M.J.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 1, 2000-01 ,pp. : 161-166

Informa Healthcare

Access to resources Recommend Favorite

Intestinal Absorption of HMG-CoA Reductase Inhibitor Pravastatin Mediated by Organic Anion Transporting Polypeptide

By Shirasaka Yoshiyuki   Suzuki Kensuke   Nakanishi Takeo   Tamai Ikumi  

Pharmaceutical Research, Vol. 27, Iss. 10, 2010-10 ,pp. : 2141-2149

Springer Publishing Company

Access to resources Recommend Favorite

In vitro inhibition of simvastatin metabolism, a HMG-CoA reductase inhibitor in human and rat liver by bergamottin, a component of grapefruit juice

By Le Goff-Klein N.   Koffel J.-C.   Jung L.   Ubeaud G.  

European Journal of Pharmaceutical Sciences, Vol. 18, Iss. 1, 2003-01 ,pp. : 31-35

Elsevier

Access to resources Recommend Favorite